Article
ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype.
Arteriosclerosis, thrombosis, and vascular biology - 1 Aug 2000
Minihane A M, Khan S, Leigh-Firbank E C, Talmud P, Wright J W, Murphy M C, Griffin B A, Williams C M
Abstract excerpt
The study assessed the efficacy of fish oil supplementation in counteracting the classic dyslipidemia of the atherogenic lipoprotein phenotype (ALP). In addition, the impact of the common apolipoprotein E (apoE) polymorphism on the fasting and postprandial lipid profile and on responsiveness to the dietary intervention was established. Fifty-five ALP males (aged 34 to 69 years, body mass index 22 to 35 kg/m(2),...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
